Risk stratification of coronary revascularization patients by using clinical and angiographic data

M Goto1, S Kohsaka, V V Lee

  • 1Kyoto University Health Service, Kyoto, Japan. goto@msa.biglobe.ne.jp

Insights

A new risk model predicts three-year mortality after coronary revascularization. Heart failure history, proximal left circumflex artery lesions, and age are key predictors for stratifying patients into low, intermediate, and high-risk groups.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Patients undergoing coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) face significant long-term mortality risks.
  • Preoperative and preprocedural factors are primary drivers of this mortality.
  • A practical method for predicting survival post-revascularization is needed.

Purpose of the Study:

  • To develop a classification tree model for predicting mid-term survival after coronary revascularization.
  • To identify key risk factors for mortality in patients undergoing CABG or PCI.

Main Methods:

  • Retrospective analysis of 3387 patients undergoing PCI or CABG.
  • Examined all-cause three-year mortality.
  • Utilized recursive partitioning to develop a risk stratification model.

Main Results:

  • History of heart failure (HF) was the strongest predictor of three-year mortality.
  • Age > 65 and proximal left circumflex artery (pLCX) lesions were significant predictors.
  • Patients were stratified into low (2.3%), intermediate, and high (36.2%) risk groups.
  • pLCX stenosis independently predicted mortality in HF patients (HR, 1.46).

Conclusions:

  • A risk stratification scheme effectively categorizes patients into low, intermediate, and high-risk groups for three-year mortality.
  • Proximal left circumflex artery stenosis is a crucial prognostic factor for patients with a history of heart failure.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...